KCNS2
| Official symbol: | KCNS2 |
| Full name: | potassium voltage-gated channel modifier subfamily S member 2 |
| Location: | 8q22.2 |
| Also known as: | Kv9.2 |
| Entrez ID: | 3788 |
| Ensembl ID: | ENSG00000156486 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 0 |
|
|
|
| |
|
|
|
| Functional class: | Ion channel |
| JensenLab PubMed score: | 1.22 (Percentile rank: 12.69%) |
| PubTator score: | 1.01 (Percentile rank: 11.46%) |
| Target development/druggability level: | TclinThese targets have activities in DrugCentral (ie. approved drugs) with known mechanism of action. |
| Tractability (small molecule): | Clinical PrecedenceTargets with drugs in phase II or above; Pre-clinical targets |
| Tractability (antibody): | Predicted Tractable - High confidenceTargets located in the plasma membrane; Targets with GO cell component terms plasma membrane or secreted |
